Department of Physiology, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Department of Physiology, Kerman University of Medical Sciences, Kerman, Iran.
Iran J Basic Med Sci. 2014 Jun;17(6):406-10.
This study was carried out to investigate the effects of COX-2 selective inhibitor (Celecoxib) or non-selective COX inhibitor (Ibuprofen) on gastrointestinal motility.
THE RATS WERE RANDOMLY DIVIDED INTO FIVE GROUPS INCLUDING: intact, sham, traumatic brain injury (TBI) group (intact rats under TBI), Celecoxib group (10 mg/kg), Ibuprofen group (10 mg/kg). Rats of the treatment groups received gavages at 1 hr before the TBI induction. The TBI was moderate and diffused using the Marmarou method. The gastric emptying and small intestine transit were measured by phenol red method.
The gastric emptying didn't change following TBI induction compared to intact group. The consumption of ibuprofen or celecoxib didn't have any effect on gastric emptying compared to sham group. TBI induction didn't have any effect on the intestinal transit. Also, there was no significant difference between ibuprofen or celecoxib consumption vs. sham group (P>0.05).
The COX-2 selective inhibitor (celecoxib) or non-selective COX inhibitor (ibuprofen) have no effects on gastric or small bowel transit. Further work is necessary to investigate the effects of non-selective COX inhibitors and their impact on gastrointestinal motility disorders.
本研究旨在探讨 COX-2 选择性抑制剂(塞来昔布)或非选择性 COX 抑制剂(布洛芬)对胃肠道动力的影响。
将大鼠随机分为五组:完整组、假手术组、创伤性脑损伤(TBI)组(TBI 下的完整大鼠)、塞来昔布组(10mg/kg)、布洛芬组(10mg/kg)。治疗组大鼠在 TBI 诱导前 1 小时进行灌胃。采用 Marmarou 法使 TBI 中度且弥散。采用酚红法测量胃排空和小肠转运。
与完整组相比,TBI 诱导后胃排空没有变化。与假手术组相比,布洛芬或塞来昔布的消耗对胃排空没有影响。TBI 诱导对肠转运没有影响。此外,布洛芬或塞来昔布的消耗与假手术组之间没有显著差异(P>0.05)。
COX-2 选择性抑制剂(塞来昔布)或非选择性 COX 抑制剂(布洛芬)对胃或小肠转运没有影响。需要进一步研究非选择性 COX 抑制剂及其对胃肠道动力障碍的影响。